JRJulie E. Raab

Julie E. Raab

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Julie E. Raab has a total of 48 co-authors. Here are the top co-authors by number of shared publications:

  • Brian C. Russo

    Department of Immunology and Microbiology, University of Colorado – Anschutz Medical Campus, School of Medicine

    3 shared publications
  • Adrian B. McDermott

    Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA

    2 shared publications
  • Grace L. Chen

    Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20902, USA

    2 shared publications
  • Jody D. Toperzer

    Department of Immunology and Microbiology, University of Colorado—Anschutz Medical Campus

    2 shared publications
  • Lauren Y. Cominsky

    Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20902, USA

    2 shared publications
  • Masaru Kanekiyo

    Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA

    2 shared publications

Latest Publications

  • Open Access

    A translocation-competent pore is required for Shigella flexneri to escape from the double membrane vacuole during intercellular spread

    by Julie E. Raab, Tucker B. Harju, Jody D. Toperzer, Jeffrey K. Duncan-Lowey, Connon I. Thomas, Anza Darehshouri, Marcia B. Goldberg, Brian C. Russo

    Type 3 secretion systems (T3SSs) enable bacterial virulence by translocating virulence proteins (effectors) into host cells. Shigella flexneri requires T3SS to invade and to spread between cells in the colon. To spread, S. flexneri forms membrane protrusions that push into the adjacent host cell. These protrusions are resolved into double membrane vacuoles (DMVs) that the bacteria quickly escape. The mechanisms required for escape from the DMV are poorly understood, but the T3SS translocon pore protein IpaC is essential. Here, we show IpaC forms a pore that is competent for the translocation of T3SS effectors as bacteria spread between cells. To do so, we used a genetic approach to test mutations of IpaC that disrupt its ability to translocate and to form pores. We show that during spread, IpaC is efficiently inserted into the plasma membrane, the membrane-embedded IpaC forms pore complexes, and the IpaC-dependent pores translocate effectors that are necessary for S. flexneri to escape the DMV. We show that T3SS activation is regulated through a distinct mechanism at spread compared to invasion; activation of T3SS secretion does not require pore formation during spread. We further show that IpaC enables a sequential breakdown of the membranes of the DMV. Thus, we show that a distinct regulation of the T3SS during S. flexneri intercellular spread enables the placement of effectors both around S. flexneri and across membranes of the DMV. Altogether, this study provides new insights into how S. flexneri escapes the DMV. IMPORTANCE: The type 3 secretion system (T3SS) is required for virulence inmany bacterial pathogens that infect humans. The T3SS forms a pore through which virulence proteins are delivered into host cells, enabling bacterial infection. Our work investigates the Shigella translocon pore protein IpaC, which is essential not only for bacteria to invade cells but also for bacteria to spread between cells. The ability to spread between cells is essential for pathogenesis; thus, understanding the mechanisms that enable spread is important for determining how S. flexneri infection causes illness. We show that IpaC delivers virulence factors across the host membrane for S. flexneri to efficiently spread. This study furthers our understanding of the mechanisms involved in T3SS secretion and of translocon pore function during S. flexneri intercellular spread.


  • Pushing boundaries: mechanisms enabling bacterial pathogens to spread between cells

    by Julie E. Raab, Desmond J. Hamilton, Tucker B. Harju, Thao N. Huynh, Brian C. Russo

    For multiple intracellular bacterial pathogens, the ability to spread directly into adjacent epithelial cells is an essential step for disease in humans. For pathogens such as Shigella , Listeria , Rickettsia , and Burkholderia , this intercellular movement frequently requires the pathogens to manipulate the host actin cytoskeleton and deform the plasma membrane into structures known as protrusions, which extend into neighboring cells. The protrusion is then typically resolved into a double-membrane vacuole (DMV) from which the pathogen quickly escapes into the cytosol, where additional rounds of intercellular spread occur. Significant progress over the last few years has begun to define the mechanisms by which intracellular bacterial pathogens spread. This review highlights the interactions of bacterial and host factors that drive mechanisms required for intercellular spread with a focus on how protrusion structures form and resolve.


  • Open Access

    Immune memory shapes human polyclonal antibody responses to H2N2 vaccination

    by Yuhe R. Yang, Julianna Han, Hailee R. Perrett, Sara T. Richey, Abigail M. Jackson, Alesandra J. Rodriguez, Rebecca A. Gillespie, Sarah O’connell, Julie E. Raab, Lauren Y. Cominsky, et al.

    Summary: Influenza A virus subtype H2N2, which caused the 1957 influenza pandemic, remains a global threat. A recent phase I clinical trial investigating a ferritin nanoparticle displaying H2 hemagglutinin in H2-naïve and H2-exposed adults. Therefore, we could perform comprehensive structural and biochemical characterization of immune memory on the breadth and diversity of the polyclonal serum antibody response elicited after H2 vaccination. We temporally map the epitopes targeted by serum antibodies after first and second vaccinations and show previous H2 exposure results in higher responses to the variable head domain of hemagglutinin while initial responses in H2-naïve participants are dominated by antibodies targeting conserved epitopes. We use cryo-EM and monoclonal B cell isolation to describe the molecular details of cross-reactive antibodies targeting conserved epitopes on the hemagglutinin head including the receptor binding site and a new site of vulnerability deemed the medial junction. Our findings accentuate the impact of pre-existing influenza exposure on serum antibody responses. Highlights: Serum Abs after first H2-F vaccination in H2-exposed donors bound variable HA head epitopes Serum Abs after first H2-F vaccination in H2-naïve donors bound conserved HA head and stem epitopes RBS-targeting VH1-69 cross-reactive antibodies were induced in H2-naïve individuals The medial junction is a previously uncharacterized conserved epitope on the HA head


  • Open Access

    Synaptopodin is necessary for Shigella flexneri intercellular spread

    by Jenna M. Vickery, Jody D. Toperzer, Julie E. Raab, Laurel L. Lenz, Sean P. Colgan, Brian C. Russo

    For many intracellular pathogens, their virulence depends on an ability to spread between cells of an epithelial layer. For intercellular spread to occur, these pathogens deform the plasma membrane into a protrusion structure that is engulfed by the neighboring cell. Although the polymerization of actin is essential for spread, how these pathogens manipulate the actin cytoskeleton in a manner that enables protrusion formation is still incompletely understood. Here, we identify the mammalian actin binding protein synaptopodin as required for efficient intercellular spread. Using a model cytosolic pathogen, Shigella flexneri , we show that synaptopodin contributes to organization of actin around bacteria and increases the length of the actin tail at the posterior pole of the bacteria. We show that synaptopodin presence enables protrusions to form and to resolve at a greater rate, indicating that greater stability of the actin tail enables the bacteria to push against the membrane with greater force. We demonstrate that synaptopodin recruitment around bacteria requires the bacterial protein IcsA, and we show that this recruitment is further enhanced in a type 3 secretion system dependent manner. These data establish synaptopodin as required for intracellular bacteria to reprogram the actin cytoskeleton in a manner that enables efficient protrusion formation and enhance our understanding of the cellular function of synaptopodin. Authors Summary: Intercellular spread is essential for many cytosolic dwelling pathogens during their infectious life cycle. Despite knowing the steps required for intercellular spread, relatively little is known about the host-pathogen interactions that enable these steps to occur. Here, we identify a requirement for the actin binding protein synaptopodin during intercellular spread by cytosolic bacteria. We show synaptopodin is necessary for the stability and recruitment of polymerized actin around bacteria. We also demonstrate synaptopodin is necessary to form plasma membrane structures known as protrusions that are necessary for the movement of these bacteria between cells. Thus, these findings implicate synaptopodin as an important actin-binding protein for the virulence of intracellular pathogens that require the actin cytoskeleton for their spread between cells.


  • An influenza H1 hemagglutinin stem-only immunogen elicits a broadly cross-reactive B cell response in humans

    by Sarah F. Andrews, Lauren Y. Cominsky, Geoffrey D. Shimberg, Rebecca A. Gillespie, Jason Gorman, Julie E. Raab, Joshua Brand, Adrian Creanga, Suprabhath R. Gajjala, Sandeep Narpala, et al.

    Current yearly seasonal influenza vaccines primarily induce an antibody response directed against the immunodominant but continually diversifying hemagglutinin (HA) head region. These antibody responses provide protection against the vaccinating strain but little cross-protection against other influenza strains or subtypes. To focus the immune response on subdominant but more conserved epitopes on the HA stem that might protect against a broad range of influenza strains, we developed a stabilized H1 stem immunogen lacking the immunodominant head displayed on a ferritin nanoparticle (H1ssF). Here, we evaluated the B cell response to H1ssF in healthy adults ages 18 to 70 in a phase 1 clinical trial (NCT03814720). We observed both a strong plasmablast response and sustained elicitation of cross-reactive HA stem–specific memory B cells after vaccination with H1ssF in individuals of all ages. The B cell response was focused on two conserved epitopes on the H1 stem, with a highly restricted immunoglobulin repertoire unique to each epitope. On average, two-thirds of the B cell and serological antibody response recognized a central epitope on the H1 stem and exhibited broad neutralization across group 1 influenza virus subtypes. The remaining third recognized an epitope near the viral membrane anchor and was largely limited to H1 strains. Together, we demonstrate that an H1 HA immunogen lacking the immunodominant HA head produces a robust and broadly neutralizing HA stem–directed B cell response.